NSE · FORTIS.NS
Fortis Healthcare Limited
₹765.20+₹10.30 (+1.36%)
Fortis Healthcare Limited’s quoted price sits in the lower half of its reported 52-week range, 27.64% below the high.
Loading market information…
NSE · INDRAMEDCO.NS · INR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:12 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Indraprastha Medical Corporation Limited’s quoted price sits in the lower half of its reported 52-week range, 51.84% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Indraprastha Medical Corporation Limited’s forward annual dividend is ₹4.00 per share, paid annual. The forward yield is 1.3% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Indraprastha Medical Corporation Limited’s next earnings report is currently expected on Oct 30, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Indraprastha Medical Corporation Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Indraprastha Medical Corporation Limited (IMCL) is a prominent Indian healthcare provider, delivering a broad spectrum of hospital services across the nation. The company offers comprehensive medical and surgical solutions across an extensive range of specialties. Its offerings encompass areas like anesthesiology, pediatrics, elder care, genomic medicine, preventative health checks, and a variety of complex surgical interventions, including bariatric, metabolic, bone marrow, cardiac, endovascular, laparoscopic, robotic, spine, pediatric urology, pediatric surgery, transplant, and urology and andrology. Furthermore, IMCL provides specialized medical departments for cancer, cardiology, dermatology, dietetics and clinical nutrition, emergency care, endocrinology/diabetes, ENT, fetal medicine, gastroenterology and hepatology, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, internal medicine, laboratory services, neonatology, nephrology, neurosciences, nuclear medicine, ophthalmology, orthopedics, physiotherapy and rehabilitation, psychiatry and clinical psychology, radiology/radio diagnosis, respiratory sleep medicine and critical care, rheumatology, and transfusion medicine. In addition to its core hospital services, IMCL also operates dedicated cosmetic and dental clinics. Established in 1988, the corporation is headquartered in New Delhi, India.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:13 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| ₹3.34B+2.64% vs estimate |
| Q3 2025 | Feb 3, 2025 | ₹3.58+371.05% vs estimate | ₹3.25B+67.07% vs estimate |
|---|
| Q2 2025 | Oct 30, 2024 | ₹4.63+509.21% vs estimate | ₹3.50B+83.17% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹765.20+₹10.30 (+1.36%)
Fortis Healthcare Limited’s quoted price sits in the lower half of its reported 52-week range, 27.64% below the high.
₹1,729.60+₹15.10 (+0.88%)
Narayana Hrudayalaya Limited’s quoted price sits in the lower half of its reported 52-week range, 17.37% below the high.
₹1,290.40-₹9.30 (-0.72%)
Global Health Limited’s quoted price sits in the upper half of its reported 52-week range, 16.42% below the high.
₹939.80+₹16.50 (+1.79%)
Yatharth Hospital & Trauma Care Services Limited’s quoted price sits in the upper half of its reported 52-week range, 20.63% below the high.
₹5,765.50-₹130.50 (-2.21%)
Kovai Medical Center and Hospital Limited’s quoted price sits in the upper half of its reported 52-week range, 10.53% below the high.
₹147.90-₹1.60 (-1.07%)
KMC Speciality Hospitals (India) Limited’s quoted price sits in the upper half of its reported 52-week range, 20.36% below the high.
₹97.95-₹7.05 (-6.71%)
Aashka Hospitals Limited’s quoted price sits in the upper half of its reported 52-week range, 9.31% below the high.
₹130.95₹0.00 (0.0%)
Maitreya Medicare Ltd.’s quoted price sits in the lower half of its reported 52-week range, 55.3% below the high.
